Skip to main content
EJNMMI Research
Fig. 2 | EJNMMI Research

Fig. 2

From: 18F-Fluciclovine PET metabolic imaging reveals prostate cancer tumour heterogeneity associated with disease resistance to androgen deprivation therapy

Fig. 2

Serial (longitudinal) 18F-Fluciclovine PET/MRI imaging on the same mouse bearing either CWR22Res orthograft [a Scan 1 (before ADT) and b Scan 2 (after ADT)] or 22Rv1 orthograft [c Scan 1 and d Scan 2 (both following ADT)] (representative image of n = 4 mice for CWR22Res and n = 3 mice for 22Rv1 bearing mice). Images presented in axial and sagittal imaged field of view (upper panel and lower panel, respectively)

Back to article page